Antimicrobial agents play a pivotal role in combating infectious diseases, offering a crucial line of defense against harmful microorganisms. Antibiotics, in particular, are substances derived from living organisms or synthesized chemically, designed to inhibit the growth of bacteria or destroy them altogether. They target specific cellular components or processes, disrupting bacterial functions without harming human cells. In the realm of antiviral agents, drugs like protease inhibitors and nucleoside analogs thwart the replication of viruses by targeting key enzymes. Antifungal agents, on the other hand, combat fungal infections by disrupting cell membrane synthesis or inhibiting essential enzymes. Parasitic infections are addressed through antiparasitic agents, targeting specific metabolic pathways in parasites. The emergence of antimicrobial resistance poses a significant challenge, urging the continuous exploration of novel agents and alternative therapeutic strategies. Research in this field focuses on developing innovative antimicrobial compounds, exploring combination therapies, and understanding the mechanisms behind resistance.
Title : The role of the humoral innate immune system in evasion of streptococcus pyogenes infections
Francis J. Castellino, University of Notre Dame, United States
Title : Global environmental changes and mosquito-borne diseases in coastal areas
Ranjan Ramasamy, IDFISH Technology, United States
Title : The impact of global antibiotic resistance on the healthcare system, public health, environment and society
Reza Nassiri, Michigan State University, United States
Title : Current topics of adult COVID-19, Influenza, and RS virus patients in Japan
Seki Masafumi, Saitama Medical University International Medical Center, Japan
Title : Novel nanotechnology and its potential applications
Stephen Hsu, Augusta University, United States
Title : 2000 years of pandemics: Past, present and future
Claudia Ferreira, Biophytis Sorbonne, France